Federal Register / Vol. 89, No. 228 / Tuesday, November 26, 2024 / Notices 93345 

Controlled substance Drug code Schedule 

Secobarbital ............................................................................................................................................................... 2315 II 

Glutethimide ............................................................................................................................................................... 2550 II 

1-Phenylcyclohexylamine .......................................................................................................................................... 7460 II 

Phencyclidine ............................................................................................................................................................. 7471 II 

ANPP (4-Anilino-N-phenethyl-4-piperidine) ............................................................................................................... 8333 II 

Norfentanyl (N-phenyl-N-(piperidin-4-yl) propionamide) ........................................................................................... 8366 II 

Phenylacetone ........................................................................................................................................................... 8501 II 

1-Piperidinocyclohexanecarbonitrile .......................................................................................................................... 8603 II 

Cocaine ...................................................................................................................................................................... 9041 II 

Codeine ..................................................................................................................................................................... 9050 II 

Etorphine HCl ............................................................................................................................................................ 9059 II 

Dihydrocodeine .......................................................................................................................................................... 9120 II 

Oxycodone ................................................................................................................................................................. 9143 II 

Hydromorphone ......................................................................................................................................................... 9150 II 

Ecgonine .................................................................................................................................................................... 9180 II 

Ethylmorphine ............................................................................................................................................................ 9190 II 

Hydrocodone ............................................................................................................................................................. 9193 II 

Levomethorphan ........................................................................................................................................................ 9210 II 

Levorphanol ............................................................................................................................................................... 9220 II 

Isomethadone ............................................................................................................................................................ 9226 II 

Meperidine ................................................................................................................................................................. 9230 II 

Meperidine intermediate-B ........................................................................................................................................ 9233 II 

Oliceridine (N-[(3-methoxythiophen-2yl)methyl] ({2-[9r)-9-(pyridin-2-yl)-6-oxaspiro[4.5] decan-9-yl] ethyl 

{time})amine fumarate).

9245 II 

Methadone ................................................................................................................................................................. 9250 II 

Dextropropoxyphene, bulk (non-dosage forms) ........................................................................................................ 9273 II 

Morphine .................................................................................................................................................................... 9300 II 

Thebaine .................................................................................................................................................................... 9333 II 

Oxymorphone ............................................................................................................................................................ 9652 II 

Noroxymorphone ....................................................................................................................................................... 9668 II 

Thiafentanil ................................................................................................................................................................ 9729 II 

Alfentanil .................................................................................................................................................................... 9737 II 

Remifentanil ............................................................................................................................................................... 9739 II 

Sufentanil ................................................................................................................................................................... 9740 II 

Carfentanil ................................................................................................................................................................. 9743 II 

Tapentadol ................................................................................................................................................................. 9780 II 

Fentanyl ..................................................................................................................................................................... 9801 II 

The company plans to bulk 

manufacture the listed controlled 

substances for forensic purposes, to 

research analytical reference standards 

and as Active Pharmaceutical 

Ingredients for Phase 1 trials. In 

reference to drug codes 7360 

(Marihuana), and 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture these drugs 

as synthetic. 

No other activities for these drug 

codes are authorized for this 

registration. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2024–27670 Filed 11–25–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1455] 

Bulk Manufacturer of Controlled 

Substances Application: Organix 

Chemistry Solutions, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Organix Chemistry Solutions, 

LLC has applied to be registered as a 

bulk manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplementary Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before January 27, 2025. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 27, 2025. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on October 16, 2024, 

Organix Chemistry Solutions, LLC, 32 

Cabot Road, Woburn, Massachusetts, 

01801–1004 applied to be registered as 

a bulk manufacturer of the following 

basic class(es) of controlled 

substance(s): 


lotter on DSK11XQN23PROD with NOTICES1
93346 Federal Register / Vol. 89, No. 228 / Tuesday, November 26, 2024 / Notices 

Controlled substance Drug code Schedule 

Gamma Hydroxybutyric Acid ..................................................................................................................................... 2010 I 

Lysergic acid diethylamide ........................................................................................................................................ 7315 I 

Marihuana .................................................................................................................................................................. 7360 I 

Tetrahydrocannabinols .............................................................................................................................................. 7370 I 

3,4-Methylenedioxyamphetamine .............................................................................................................................. 7400 I 

3,4-Methylenedioxymethamphetamine ...................................................................................................................... 7405 I 

5-Methoxy-N–N-dimethyltryptamine .......................................................................................................................... 7431 I 

Alpha-Methyltryptamine ............................................................................................................................................. 7432 I 

Bufotenine .................................................................................................................................................................. 7433 I 

Diethyltryptamine ....................................................................................................................................................... 7434 I 

Dimethyltryptamine .................................................................................................................................................... 7435 I 

Psilocybin ................................................................................................................................................................... 7437 I 

Psilocyn ..................................................................................................................................................................... 7438 I 

2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) ............................................................................................ 7508 I 

2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) ........................................................................................................... 7517 I 

Heroin ........................................................................................................................................................................ 9200 I 

Morphine .................................................................................................................................................................... 9300 II 

The company plans to synthesize the 

listed controlled substances for 

distribution to its customers. In 

reference to drug codes 7360 

(Marihuana), and 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture these drugs 

as synthetic. No other activities for these 

drug codes are authorized for this 

registration. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2024–27674 Filed 11–25–24; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1446] 

Importer of Controlled Substances 

Application: National Center for 

Natural Products Research 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: National Center for Natural 

Products Research has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to Supplementary Information 

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before December 26, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before December 26, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on September 16, 2024, 

National Center for Natural Products 

Research, 806 Hathorn Road, 135 Coy 

Waller Lab, University, Mississippi 

38677 applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Marihuana ...................... 7360 I 

Tetrahydrocannabinols .. 7370 I 

The company plans to acquire new 

genetic materials with improved 

cannabinoids for research and 

manufacturing purposes. No other 

activities for these drug codes are 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2024–27694 Filed 11–25–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1458] 

Bulk Manufacturer of Controlled 

Substances Application: Isosciences, 

LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Isosciences, LLC has applied 

to be registered as a bulk manufacturer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before January 27, 2025. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 27, 2025. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 


lotter on DSK11XQN23PROD with NOTICES1

I I